Newbridge Financial Services Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65K | Hold |
2,356
| – | – | 0.01% | 457 |
|
|
2025
Q1 | $66.8K | Buy |
2,356
+1,255
| +114% | +$35.6K | 0.02% | 317 |
|
|
2024
Q4 | $45.8K | Sell |
1,101
-416
| -27% | -$17.3K | 0.01% | 425 |
|
|
2024
Q3 | $101K | Sell |
1,517
-261
| -15% | -$17.4K | 0.04% | 195 |
|
|
2024
Q2 | $211K | Buy |
1,778
+68
| +4% | +$8.08K | 0.08% | 176 |
|
|
2024
Q1 | $182K | Sell |
1,710
-116
| -6% | -$12.4K | 0.08% | 205 |
|
|
2023
Q4 | $182K | Buy |
1,826
+50
| +3% | +$4.97K | 0.09% | 200 |
|
|
2023
Q3 | $183K | Buy |
1,776
+120
| +7% | +$12.4K | 0.09% | 198 |
|
|
2023
Q2 | $201K | Sell |
1,656
-58
| -3% | -$7.05K | 0.1% | 199 |
|
|
2023
Q1 | $263K | Hold |
1,714
| – | – | 0.14% | 149 |
|
|
2022
Q4 | $308K | Buy |
1,714
+157
| +10% | +$28.2K | 0.18% | 123 |
|
|
2022
Q3 | $184K | Buy |
1,557
+92
| +6% | +$10.9K | 0.11% | 199 |
|
|
2022
Q2 | $209K | Buy |
1,465
+200
| +16% | +$28.5K | 0.13% | 159 |
|
|
2022
Q1 | $218K | Buy |
1,265
+183
| +17% | +$31.5K | 0.11% | 185 |
|
|
2021
Q4 | $275K | Buy |
1,082
+64
| +6% | +$16.3K | 0.13% | 158 |
|
|
2021
Q3 | $392K | Buy |
1,018
+572
| +128% | +$220K | 0.25% | 94 |
|
|
2021
Q2 | $105K | Sell |
446
-250
| -36% | -$58.9K | 0.06% | 275 |
|
|
2021
Q1 | $91K | Buy |
696
+141
| +25% | +$18.4K | 0.07% | 271 |
|
|
2020
Q4 | $58K | Sell |
555
-449
| -45% | -$46.9K | 0.05% | 299 |
|
|
2020
Q3 | $71K | Buy |
+1,004
| New | +$71K | 0.07% | 245 |
|